These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Inducing Mucosal IgA: A Challenge for Vaccine Adjuvants and Delivery Systems. Boyaka PN J Immunol; 2017 Jul; 199(1):9-16. PubMed ID: 28630108 [TBL] [Abstract][Full Text] [Related]
10. Effective mucosal immunity to anthrax: neutralizing antibodies and Th cell responses following nasal immunization with protective antigen. Boyaka PN; Tafaro A; Fischer R; Leppla SH; Fujihashi K; McGhee JR J Immunol; 2003 Jun; 170(11):5636-43. PubMed ID: 12759444 [TBL] [Abstract][Full Text] [Related]
11. [Mucosal immunity and vaccine development]. Anjuère F; Czerkinsky C Med Sci (Paris); 2007 Apr; 23(4):371-8. PubMed ID: 17433226 [TBL] [Abstract][Full Text] [Related]
12. Mucosal immunisation and adjuvants: a brief overview of recent advances and challenges. Holmgren J; Czerkinsky C; Eriksson K; Mharandi A Vaccine; 2003 Jun; 21 Suppl 2():S89-95. PubMed ID: 12763689 [TBL] [Abstract][Full Text] [Related]
13. Mucosal immune network in the gut for the control of infectious diseases. Iijima H; Takahashi I; Kiyono H Rev Med Virol; 2001; 11(2):117-33. PubMed ID: 11262530 [TBL] [Abstract][Full Text] [Related]
14. A mucosal IgA response, but no systemic antibody response, is evoked by intranasal immunisation of dogs with Echinococcus granulosus surface antigens iscoms. Carol H; Nieto A Vet Immunol Immunopathol; 1998 Sep; 65(1):29-41. PubMed ID: 9802574 [TBL] [Abstract][Full Text] [Related]
15. The common mucosal immune system and current strategies for induction of immune responses in external secretions. Mestecky J J Clin Immunol; 1987 Jul; 7(4):265-76. PubMed ID: 3301884 [TBL] [Abstract][Full Text] [Related]
16. Intranasal immunization with plasmid DNA-lipid complexes elicits mucosal immunity in the female genital and rectal tracts. Klavinskis LS; Barnfield C; Gao L; Parker S J Immunol; 1999 Jan; 162(1):254-62. PubMed ID: 9886393 [TBL] [Abstract][Full Text] [Related]
17. Membrane-anchored CCL20 augments HIV Env-specific mucosal immune responses. Sun X; Zhang H; Xu S; Shi L; Dong J; Gao D; Chen Y; Feng H Virol J; 2017 Aug; 14(1):163. PubMed ID: 28830557 [TBL] [Abstract][Full Text] [Related]
18. Oral administration of immunomodulators and the mucosal immune system. Revillard JP; Cozon G; Czerkinsky C Dev Biol Stand; 1992; 77():31-7. PubMed ID: 1426671 [TBL] [Abstract][Full Text] [Related]
19. In defense of mucosal surfaces. Development of novel vaccines for IgA responses protective at the portals of entry of microbial pathogens. McGhee JR; Mestecky J Infect Dis Clin North Am; 1990 Jun; 4(2):315-41. PubMed ID: 2189002 [TBL] [Abstract][Full Text] [Related]
20. Natural killer T cell and TLR9 agonists as mucosal adjuvants for sublingual vaccination with clade C HIV-1 envelope protein. Singh S; Yang G; Byrareddy SN; Barry MA; Sastry KJ Vaccine; 2014 Dec; 32(51):6934-6940. PubMed ID: 25444819 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]